Abstract
Estradiol-17β (E
2) increases creatine kinase (CK) specific activity in aorta (Ao) and left ventricle of the heart (Lv) from rat females. In the present study, we analyzed the effects of pretreatment with the non calcemic analog of vitamin D, JK 1624 F2-2 (JKF) on the response to E
2 (either 0.5 or 5
μg/rat) of Ao and Lv from prepubertal female rats. JKF did not affect CK in either organ. However, pretreatment with JKF (0.1
ng/g body weight for 1 or 2 weeks) increased the CK response to E
2 (0.5
μg/rat) by 50±10% in Ao and by 150±12% in Lv. The CK response to 5
μg/rat of E
2 in intact female rats, was increased by 118±15% and 99±11% in the Ao and by 89±6% and 112±13% in the Lv, in animals treated daily with JKF for 1 or 2 weeks, respectively, before administration of E
2. JKF also increased the response to 500
μg/rat raloxifene (Ral) by 47±8% in Ao and by 56±12% in Lv. Preliminary experiments showed that JKF treatment induced a ∼50% increase in estradiol receptor ERα in both organs. The results indicate that the vitamin D analog JKF upregulates the response and sensitivity of vascular tissues to E
2, in association with increased expression of their ERα. These results should prompt examination of the possibility that the effects estrogen therapy in postmenopausal women can be augmented by vitamin D or its analogs.